Progress against Alzheimer’s
Two Alzheimer’s drugs, lecanemab and donanemab, have been approved in the US. At a recent gathering organized by the Goulandris Foundation and the Hellenic Initiative Against Alzheimer’s, new research on lecanemab was presented.

